Synuclein 2025 Meeting Cambridge, UK 8th -11th April.
TRIAL NOW RECRUITING – IONIS
INTERESTED IN A RESEARCH STUDY? VISIT THE LINK BELOW TO LEARN MORE: IONIS STUDY: https://ionistrials.com/study/study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-ion464-administered-to-adults-with-multiple-system-atrophy-horizon/
TRIAL NOW RECRUITING – ASK BIO
INTERESTED IN THIS RESEARCH STUDY? VISIT THE LINK BELOW TO LEARN MORE: ASK BIO: https://www.askbio.com/multiple-system-atrophy-msa-clinical-trial/
TRIAL NOW RECRUITING – THERAVANCE
INTERESTED IN THIS STUDY? VISIT THE LINK BELOW TO LEARN MORE: THERAVANCE: https://www.cypress-study.com/
TRIAL NOW RECRUITING – ONO
INTERESTED IN THIS STUDY? VISIT THE LINK BELOW TO LEARN MORE: ONO: https://clinicaltrials.gov/study/NCT05923866
Now Recruiting – New MSA Drug Trial
For More Info on Inclusion/Exclusion Criteria & Locations, Visit: https://clinicaltrials.gov/study/NCT05923866?cond=Multiple%20System%20Atrophy,%20MSA&term=Ono&rank=1
NEW ORTHOSTATIC HYPOTENSION (NOH STUDY)
LEARN ABOUT THIS STUDY – WITH STUDY CENTERS IN USA AND OUTSIDE OF USA HERE: https://cypress-study.com/ Theravance Biopharma is researching the investigational drug (ampreloxetine) because they believe it may reduce nOH symptoms that interfere with daily activity in MSA patients based on prior clinical trial results. They are running the Phase 3 CYPRESS trial to […]
MSA Drug Repurposing Exploratory Fund
VISIT HERE TO DONATE: WWW.DEFEATMSA.ORG/DONATE
